﻿<?xml version="1.0" encoding="utf-8"?><!--RSS Genrated: Thu, 16 Apr 2026 07:09:18 GMT--><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:ev="http://purl.org/rss/1.0/modules/event/"><channel><title>American Pharmacists Association</title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/December-2021/rss/1958</link><atom:link href="http://www.pharmacist.com/Publications/Pharmacy-Today/December-2021/rss/1958" rel="self" type="application/rss+xml" /><description>RSS document</description><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[New and Approved]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/new-and-approved-22</link><description><![CDATA[  New formulation  

 NALOXONE HYDROCHLORIDE 
(ZIMHI—Adamis Pharmaceuticals Corporation) 

  Drug class:  Opioid antagonist. 

  Indication:  Emergency treatment for known or suspected opioid ...]]></description><pubDate>Tue, 07 Dec 2021 17:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/new-and-approved-22</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2443]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Rethinking statin adverse effects and factoring in the “nocebo” effect]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/rethinking-statin-adverse-effects-and-factoring-in-the-nocebo-effect</link><description><![CDATA[  Maria G. Tanzi, PharmD  

   

 Results of a September 2021 study by Howard and colleagues published in the  Journal of the American College of Cardiology  show that, in patients with a history ...]]></description><pubDate>Tue, 07 Dec 2021 17:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/rethinking-statin-adverse-effects-and-factoring-in-the-nocebo-effect</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2437]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[DEA issues safety alert on counterfeit meds]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/dea-issues-safety-alert-on-counterfeit-meds</link><description><![CDATA[  Loren Bonner  

   

 The DEA is alerting the public to the dangers of counterfeit medications containing the powerful synthetic opioid fentanyl. 

 More than 9.5 million of these counterfeit ...]]></description><pubDate>Tue, 07 Dec 2021 17:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/dea-issues-safety-alert-on-counterfeit-meds</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2438]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Should medical cannabis be used to treat chronic pain?]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/should-medical-cannabis-be-used-to-treat-chronic-pain-1</link><description><![CDATA[  Clarissa Chan, PharmD  

   

 According to CDC, people most often cite pain management as their reason for using medical cannabis in the United States. But a new clinical practice guideline ...]]></description><pubDate>Tue, 07 Dec 2021 17:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/should-medical-cannabis-be-used-to-treat-chronic-pain-1</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2439]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Pharmacists and hypertension management: Reflecting one year after the Surgeon General’s call to action]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/pharmacists-and-hypertension-management-reflecting-one-year-after-the-surgeon-generals-call-to-action</link><description><![CDATA[  Olivia Welter, PharmD  

   

 A CDC evaluation found that 66% of participants in a pharmacist-led hypertension program—the University of Michigan Health Hypertension Pharmacists’ ...]]></description><pubDate>Tue, 07 Dec 2021 17:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/pharmacists-and-hypertension-management-reflecting-one-year-after-the-surgeon-generals-call-to-action</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2440]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Are synbiotic supplements all they claim to be?]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/are-synbiotic-supplements-all-they-claim-to-be</link><description><![CDATA[  Johanna Taylor Katroscik  

   

 According to a 2021 article published in  Gastroenterology  by O’Connor and colleagues, approximately 1 in 20 people in the United States are using a ...]]></description><pubDate>Tue, 07 Dec 2021 17:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/are-synbiotic-supplements-all-they-claim-to-be</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2441]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Answering burning questions about heartburn and indigestion aids]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/answering-burning-questions-about-heartburn-and-indigestion-aids</link><description><![CDATA[  Daniel L. Krinsky, RPh, MS  

   

 This time of year, with all the less-than-healthy eating opportunities, heartburn and dyspepsia (indigestion) will be more prevalent—as will opportunities to ...]]></description><pubDate>Tue, 07 Dec 2021 17:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/answering-burning-questions-about-heartburn-and-indigestion-aids</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2442]]></dc:identifier></item></channel></rss>